Küsimused

Dear Sir/Madam,

Hope this email finds you well.

Could you please confirm if the provided information (in green color) for medical devices in clinical trials in Estonia is correct?

             Domestic SADEs occurring within study (yes/no)?: Yes

             Foreign SADEs occurring within study (yes/no)?: Yes.

             SADEs from other studies with same study device / Cross-reports (yes/no)?: No.

             SADE Reporting Form: Clinical Investigation Summary Safety Report Form in MDCG 2020-10/2 rev.1.

             SADE Reporting Method: Please specify the reporting method (eg: email..)

             SADE Reporting Format: Please specify the reporting Format ( e.g: pdf, excel..)

             Electronic reporting destination: [email protected]

             Additional/Exceptions to expedited 7/15 SADE reports? (Yes/No): Yes.

             if yes, please see special reporting requirements:

- Serious public health threat: 2 days.
- Death or UNANTICIPATED serious deterioration in state of health: 7 days.
- Others: 30 days.

             Periodic Line Listing required? (Yes/no) if yes, please confirm: No

• * Frequency for Line Listing: NA

• * Reporting Timeline for Periodic Line Listing (days after DLP): NA

• * Periodic Line Listing Reporting Method (e.g. e-mail, N/A, etc.): NA.

• * Periodic Line Listing Format: NA

• * Destination for electronic Line Listing: NA

• * Annual Report required? (yes/no) if yes, please confirm: No.
  
  

• * Reporting Timeline for Annual Report (days after DLP): NA.

• * Annual Report Reporting Method (e.g. courier, CESP, email etc): NA.

• * Annual Report Reporting Format (e.g. paper, CD-ROM, pdf, eCTD etc): NA.

• * Destination for electronic Annual Report submission: NA.

• * Periodic Report Special reporting requirements: NA.

• * Translation required for safety reports?: NA

• * Translation requirements - Language and report/information to be translated? (if yes, please specify the language): NA.

Thank you in advance for your time and collaboration

Ruth Jiménez (She/Her)

Submissions Associate,

Patient Safety Solutions (PSS)

Upcoming Out of Office days: 17 and 18 April 2025

E: [email protected]

 fortrea.com
Fortrea Spain SAU

Labcorp’s Clinical Development Business will become Fortrea